Eliana joined the European Vaccine Initiative in July 2019 as Project Manager. She obtained a PhD from the University of Buenos Aires, Argentina, in 2011 after investigating the endocytic pathways hitchhiked by dengue viruses to infect mammalian and mosquito cells. Subsequently she joined the group of Prof. Ralf Bartenschlager at the University Hospital Heidelberg, Germany, where she applied several molecular and cellular biology techniques to decipher the mode of action of innovative antivirals and to investigate fundamental aspects of the replication cycle of several viruses including dengue, Zika, West Nile and Hepatitis C. Eliana´s work led to more than 10 research articles published in renowned international peer-review journals and has been granted an international patent. Additionally, she authored several book chapters and reviews on virus - host cell interaction, antivirals and vaccines.
Before joining EVI, Eliana worked as Project Manager for a Deutsches Zentrum für Infektionsforschung (DZIF) project on broad-spectrum antivirals, as coordinator within the Master program “Molecular Biosciences” at the University of Heidelberg and as Scientific Writer.